Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1975 Jan 25;1(5951):185–189. doi: 10.1136/bmj.1.5951.185

Oestrogen receptors in breast cancer: a changing concept.

G Leclercq, J C Heuson, M C Deboel, W H Mattheiem
PMCID: PMC1672156  PMID: 163111

Abstract

Oestrogen receptors were found in 156 (73%) out of 214 primary breast cancers and in 98 (58%) out of 168 metastatic deposits. These proportions reached 82% and 70% respectively in the second half of the study. Receptors were not found in samples of normal breast tissue but small amounts were present in tissue from some hyperplastic lesions and in male gynaecomastia. Receptor concentrations in the malignant samples were evenly distributed over a wide range of values, suggesting that even "negative" tumours might contain trace amounts undetectable by the method used. Each tumour was characterized by a given level of receptor concentration. In most cases the amounts found in the invaded axillary nodes and their corresponding primary tumours were the same. We suggest that quantitative rather than qualitative assessment should provide an appropriate criterion for studies of biochemical and clinical correlations.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braunsberg H., James V. H., Irvine W. T., Jamieson C. W., James F., Sellwood R. A., Carter A. E., Hulbert M. Prognostic significance of oestrogen uptake by human breast-cancer tissue. Lancet. 1973 Jan 27;1(7796):163–165. doi: 10.1016/s0140-6736(73)90001-9. [DOI] [PubMed] [Google Scholar]
  2. CROSBY W. H., FURTH F. W. A modification of the benzidine method for measurement of hemoglobin in plasma and urine. Blood. 1956 Apr;11(4):380–383. [PubMed] [Google Scholar]
  3. Engelsman E., Persijn J. P., Korsten C. B., Cleton F. J. Oestrogen receptor in human breast cancer tissue and response to endocrine therapy. Br Med J. 1973 Jun 30;2(5869):750–752. doi: 10.1136/bmj.2.5869.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Feherty P., Farrer-Brown G., Kellie A. E. Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay. Br J Cancer. 1971 Dec;25(4):697–710. doi: 10.1038/bjc.1971.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hähnel R., Twaddle E., Vivian A. B. Estrogen receptors in human breast cancer. 2. In vitro binding of estradiol by benign and malignant tumors. Steroids. 1971 Dec;18(6):681–708. doi: 10.1016/0039-128x(71)90030-4. [DOI] [PubMed] [Google Scholar]
  6. Johansson H., Terenius L., Thorén L. The binding of estradiol-17beta to human breast cancers and other tissues in vitro. Cancer Res. 1970 Mar;30(3):692–698. [PubMed] [Google Scholar]
  7. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  8. Leclercq G., Heuson J. C., Schoenfeld R., Mattheiem W. H., Tagnon H. J. Estrogen receptors in human breast cancer. Eur J Cancer. 1973 Sep;9(9):665–673. doi: 10.1016/0014-2964(73)90009-1. [DOI] [PubMed] [Google Scholar]
  9. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  10. McGuire W. L., DeLaGarza M. Improved sensitivity in the measurement of estrogen receptor in human breast cancer. J Clin Endocrinol Metab. 1973 Dec;37(6):986–989. doi: 10.1210/jcem-37-6-986. [DOI] [PubMed] [Google Scholar]
  11. Sanborn B. M., Rao B. R., Korenman S. G. Interaction of 17 -estradiol and its specific uterine receptor. Evidence for complex kinetic and equilibrium behavior. Biochemistry. 1971 Dec 21;10(26):4955–4962. doi: 10.1021/bi00802a019. [DOI] [PubMed] [Google Scholar]
  12. Savlov E. D., Wittliff J. L., Hilf R., Hall T. C. Proceedings: Correlations between certain biochemical properties of breast cancer and response to therapy: a preliminary report. Cancer. 1974 Feb;33(2):303–309. doi: 10.1002/1097-0142(197402)33:2<303::aid-cncr2820330202>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  13. Spaeren U., Olsnes S., Brennhovd I., Efskind J., Pihl A. Content of estrogen receptors in human breast cancer. Eur J Cancer. 1973 May;9(5):353–357. doi: 10.1016/0014-2964(73)90050-9. [DOI] [PubMed] [Google Scholar]
  14. Trams G., Maass H. Oestrogenreceptoren in Mamma-Carcinomen und Verlauf nach endokriner Behandlung. Arch Gynakol. 1973 Sep 28;214(1):293–294. doi: 10.1007/BF00671147. [DOI] [PubMed] [Google Scholar]
  15. Wittliff J. L., Hilf R., Brooks W. F., Jr, Savlov E. D., Hall T. C., Orlando R. A. Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans. Cancer Res. 1972 Sep;32(9):1983–1992. [PubMed] [Google Scholar]
  16. Wittliff J. L. Specific receptors of the steroid hormones in breast cancer. Semin Oncol. 1974 Jun;1(2):109–118. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES